D'Angelo, D., Glieca, S., Flammini, L., Bertoni, S., Bianchera, A., Quarta, E., . . . Buttini, F. (2026). CaP-Coated Cyclosporine A Liposomes Formulated as an Inhalable Dry Powder for Lung Inflammatory Diseases. Pharmaceutics, 18(6), 684. https://doi.org/10.3390/pharmaceutics18060684
Chicago Style (17th ed.) CitationD'Angelo, Davide, Stefania Glieca, Lisa Flammini, Simona Bertoni, Annalisa Bianchera, Eride Quarta, Ben Forbes, Fabio Sonvico, and Francesca Buttini. "CaP-Coated Cyclosporine A Liposomes Formulated as an Inhalable Dry Powder for Lung Inflammatory Diseases." Pharmaceutics 18, no. 6 (2026): 684. https://doi.org/10.3390/pharmaceutics18060684.
MLA (9th ed.) CitationD'Angelo, Davide, et al. "CaP-Coated Cyclosporine A Liposomes Formulated as an Inhalable Dry Powder for Lung Inflammatory Diseases." Pharmaceutics, vol. 18, no. 6, 2026, p. 684, https://doi.org/10.3390/pharmaceutics18060684.
